InvestorsHub Logo

veto

05/10/17 7:34 PM

#107844 RE: DewmBoom #107840

Sad. No legitimate financial/marketing entity will ever want their name associated the Whalens.

DewmBoom

05/10/17 7:44 PM

#107846 RE: DewmBoom #107840

It sounds to me that the division is using the word billions of shares as a scare tactic, instead of talking about dollar amount.

However, I don't think this will pass the commission. When you read the word billions of shares, it sounds really scary. The innovative financial model that Biel managed to use to reach FDA clearance is a bit of the head of traditional thinking. Biel should be congratulated on their achievement rather than getting penalized.

TBlessed

05/10/17 8:05 PM

#107849 RE: DewmBoom #107840

Thanks DB, everyone should be interested!

Sharemaniac

05/11/17 3:05 AM

#107855 RE: DewmBoom #107840

BIEL's notes to the public markets,40 they justified this immediate harm to BIEL's shareholders
by suggesting that "all ships would rise, as the saying goes, with the success of the firm" and
FDA approval.41 Thus, BIEL concluded "as a business decision," that "it was [BIEL's] best
36

Although Mr. Whelan admitted that when
the Liquidating Entities convert their notes and sell shares of BIEL into the market, it shifts risk
onto the investing public, he expressed no concern for his own responsibility for that shift.43
Richard Staelin, BIEL's sole inqependent Board member, was similarly nonplussed. Mr. Staelin
professed that his "primary role as an independent Board member is to look out for the
shareholders and shareholder value,"44 but during Mr. Staelin's tenure on BIEL's Board, BIEL's
share price. has gone from a high of 12 cents per share in 2009, 45 to just eight one-thousandths of
a cent at the time of trial. 46 Respondents' actions deprived public investors of the knowledge
that "they [we ]re helping to support the issuer by the passing of the proceeds right back to BIEL.
If they had known that they might not have bought it. '"'7
II.